Literature DB >> 25266520

Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus.

Wei Zhang1, Jianguo Wan2, Kejian Qian1, Xiaoqing Liu3, Zuke Xiao4, Jian Sun5, Zhenguo Zeng1, Qi Wang6, Jinxiang Zhang2, Guanghui Jiang2, Cheng Nie1, Rong Jiang1, Chengzhi Ding1, Ran Li7, Peter Horby8, Zhancheng Gao9.   

Abstract

BACKGROUND: Novel influenza A viruses of avian-origin may be the precursors of pandemic strains. This descriptive study aims to introduce a novel avian-origin influenza A (H10N8) virus which can infect humans and cause severe diseases.
METHODS: Collecting clinical data of three cases of human infection with a novel reassortment avian influenza A (H10N8) virus in Nanchang, Jiangxi Province, China.
RESULTS: Three cases of human infection with a new reassortment avian influenza A(H10N8) virus were described, of which two were fatal cases, and one was severe case. These cases presented with severe pneumonia that progressed to acute respiratory distress syndrome (ARDS) and intractable respiratory failure.
CONCLUSION: This novel reassortment avian influenza A (H10N8) virus in China resulted in fatal human infections, and should be added to concerns in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266520

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  11 in total

1.  Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus.

Authors:  Irene Ramos; Mena Mansour; Teddy J Wohlbold; Megan E Ermler; Ariana Hirsh; Jonathan A Runstadler; Ana Fernandez-Sesma; Florian Krammer
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

Review 2.  The cytokine storm of severe influenza and development of immunomodulatory therapy.

Authors:  Qiang Liu; Yuan-hong Zhou; Zhan-qiu Yang
Journal:  Cell Mol Immunol       Date:  2015-07-20       Impact factor: 11.530

3.  Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant.

Authors:  Dennis Christensen; Jan P Christensen; Karen S Korsholm; Louise K Isling; Karin Erneholm; Allan R Thomsen; Peter Andersen
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

4.  A PB1-K577E Mutation in H9N2 Influenza Virus Increases Polymerase Activity and Pathogenicity in Mice.

Authors:  Haruhiko Kamiki; Hiromichi Matsugo; Tomoya Kobayashi; Hiroho Ishida; Akiko Takenaka-Uema; Shin Murakami; Taisuke Horimoto
Journal:  Viruses       Date:  2018-11-19       Impact factor: 5.048

5.  Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro.

Authors:  Zhengtu Li; Li Li; Hongxia Zhou; Lijuan Zeng; Tingting Chen; Qiaolian Chen; Beixian Zhou; Yutao Wang; Qiaoyan Chen; Ping Hu; Zifeng Yang
Journal:  Molecules       Date:  2017-01-11       Impact factor: 4.411

6.  A Multi-Hemagglutinin-Based Enzyme-Linked Immunosorbent Assay to Serologically Detect Influenza A Virus Infection in Animals.

Authors:  Miki Okumura; Akiko Takenaka-Uema; Shin Murakami; Taisuke Horimoto
Journal:  Vet Sci       Date:  2019-07-22

7.  Adaptation of H9N2 AIV in guinea pigs enables efficient transmission by direct contact and inefficient transmission by respiratory droplets.

Authors:  Xiaoyu Sang; Airong Wang; Jie Ding; Huihui Kong; Xiaolong Gao; Lin Li; Tongjie Chai; Yuanguo Li; Kun Zhang; Chengyu Wang; Zhonghai Wan; Geng Huang; Tiecheng Wang; Na Feng; Xuexing Zheng; Hualei Wang; Yongkun Zhao; Songtao Yang; Jun Qian; Guixue Hu; Yuwei Gao; Xianzhu Xia
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

Review 8.  Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9.

Authors:  Pengfei Wei; Zelang Cai; Jinwen Hua; Weijia Yu; Jiajie Chen; Kang Kang; Congling Qiu; Lanlan Ye; Jiayun Hu; Kunmei Ji
Journal:  Biomed Res Int       Date:  2016-07-20       Impact factor: 3.411

9.  Amino Acid Substitutions Associated with Avian H5N6 Influenza A Virus Adaptation to Mice.

Authors:  Chunmao Zhang; Zongzheng Zhao; Zhendong Guo; Jiajie Zhang; Jiaming Li; Yifei Yang; Shaoxia Lu; Zhongyi Wang; Min Zhi; Yingying Fu; Xiaoyu Yang; Lina Liu; Yi Zhang; Yuping Hua; Linna Liu; Hongliang Chai; Jun Qian
Journal:  Front Microbiol       Date:  2017-09-15       Impact factor: 5.640

10.  Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.

Authors:  Kapil Bahl; Joe J Senn; Olga Yuzhakov; Alex Bulychev; Luis A Brito; Kimberly J Hassett; Michael E Laska; Mike Smith; Örn Almarsson; James Thompson; Amilcar Mick Ribeiro; Mike Watson; Tal Zaks; Giuseppe Ciaramella
Journal:  Mol Ther       Date:  2017-04-27       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.